Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
  2. Saleh, Anthony D.; Cheng, Hui; Martin, Scott E.; Si, Han; Ormanoglu, Pinar; Carlson, Sophie; Clavijo, Paul E.; Yang, Xinping; Das, Rita; Cornelius, Shaleeka; Couper, Jamie; Chepeha, Douglas; Danilova, Ludmila; Harris, Thomas M.; Prystowsky, Michael B.; Childs, Geoffrey J.; Smith, Richard; Robertson, A. Gordon; Jones, Steven J. M.; Cherniack, Andrew D.; Kim, Sang S.; Rait, Antonina; Pirollo, Kathleen F.; Chang, Esther H.; Chen, Zhong; Van Waes, Carter
  3. CLINICAL CANCER RESEARCH. 2019, MAY 1; 25(9): 2860-2873.
  1. 2.   Advances in Breast Cancer Therapy Using Nitric Oxide and Nitroxyl Donor Agents
  2. Basudhar, Debashree; Miranda, Katrina M.; Wink, David; Ridnour, Lisa
  3. REDOX-ACTIVE THERAPEUTICS. 2016; : 377-403.
  1. 3.   The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres
  2. Cabarcas, S. M.; Thomas, S.; Zhang, X. H.; Cherry, J. M.; Sebastian, T.; Yerramilli, S.; Lader, E.; Farrar, W. L.; Hurt, E. M.
  3. Genomics. 2012, Feb; 99(2): 108-117.
  1. 4.   Dysregulated Delta Np63 alpha Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes
  2. Ha, L. A.; Ponnamperuma, R. M.; Jay, S.; Ricci, M. S.; Weinberg, W. C.
  3. Plos One. 2011, Jul; 6(7): 13.
  1. 5.   Cancer and Inflammation: Promise for Biologic Therapy
  2. Demaria, S.; Pikarsky, E.; Karin, M.; Coussens, L. M.; Chen, Y. C.; El-Omar, E. M.; Trinchieri, G.; Dubinett, S. M.; Mao, J. T.; Szabo, E.; Krieg, A.; Weiner, G. J.; Fox, B. A.; Coukos, G.; Wang, E.; Abraham, R. T.; Carbone, M.; Lotze, M. T.
  3. Journal of Immunotherapy. 2010, May; 33(4): 335-351.
  1. 6.   Reduction of IKK alpha Expression Promotes Chronic Ultraviolet B Exposure-Induced Skin Inflammation and Carcinogenesis
  2. Xia, X. J.; Park, E.; Liu, B. G.; Willette-Brown, J.; Gong, W. H.; Wang, J. M.; Mitchell, D.; Fischer, S. M.; Hu, Y. L.
  3. American Journal of Pathology. 2010, May; 176(5): 2500-2508.
  1. 7.   Aryl Hydrocarbon Receptor Expression Is Associated with a Family History of Upper Gastrointestinal Tract Cancer in a High-Risk Population Exposed to Aromatic Hydrocarbons
  2. Roth, M. J.; Wei, W. Q.; Baer, J.; Abnet, C. C.; Wang, G. Q.; Sternberg, L. R.; Warner, A. C.; Johnson, L. L.; Lu, N.; Giffen, C. A.; Dawsey, S. M.; Qiao, Y. L.; Cherry, J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(9): 2391-2396.
  1. 8.   Proteomic analysis of laser-captured paraffin-embedded tissues: A molecular portrait of head and neck cancer progression
  2. Patel, V.; Hood, B. L.; Molinolo, A.; Lee, N. H.; Conrads, T. P.; Braisted, J. C.; Krizman, D. B.; Veenstra, T. D.; Gutkind, J. S.
  3. Clinical Cancer Research. 2008 14(4): 1002-1014.
  1. 9.   Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors
  2. Mechanic, L. E.; Bowman, E. D.; Welsh, J. A.; Khan, M. A.; Hagiwara, N.; Enewold, L.; Shields, P. G.; Burdette, L.; Chanock, S.; Harris, C. C.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Feb; 16(2): 214-222.
  1. 10.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 11.   Abnormal gene expression profiles in unaffected parents of patients with hereditary-type retinoblastoma
  2. Chuang, E. Y.; Chen, X.; Tsai, M. H.; Yan, H. L.; Li, C. Y.; Mitchell, J. B.; Nagasawa, H.; Wilson, P. F.; Peng, Y. L.; Fitzek, M. M.; Bedford, J. S.; Little, J. B.
  3. Cancer Research. 2006, Apr; 66(7): 3428-3433.
  1. 12.   Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Kimura, T.; Fujita, M.; Nakashima, R.; Ueda, Y.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Tanigami, A.; Yoshino, K.; Murata, Y.
  3. Cancer Research. 2005, OCT 1; 65(19): 8640-8645.
  1. 13.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 14.   Epigenetic inactivation of RASSF1A in head and neck cancer
  2. Dong, S. M.; Sun, D. I.; Benoit, N. E.; Kuzmin, I.; Lerman, M. I.; Sidransky, D.
  3. Clinical Cancer Research. 2003 9(10, Part 1): 3635-3640.
  1. 15.   Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta 1 heterozygous mice
  2. Kang, Y.; Ozbun, L. L.; Angdisen, J.; Moody, T. W.; Prentice, M.; Diwan, B. A.; Jakowlew, S. B.
  3. Carcinogenesis. 2002 23(7): 1217-1227.
  1. 16.   Hematopoietic switch from lymphoid to granulocytic development in 3LL tumor-bearing mice
  2. Lee, J. K.; Back, T. C.; Komschlies, K. L.; Ruscetti, F. W.; Young, H. A.; Wiltrout, R. H.
  3. In Vivo. 2001 15(4): 255-263.
  1. 17.   Proteomic profiling of the cancer microenvironment by antibody arrays
  2. Knezevic, V.; Leethanakul, C.; Bichsel, V. E.; Worth, J. M.; Prabhu, V. V.; Gutkind, J. S.; Liotta, L. A.; Munson, P. J.; Petricoin, E. F.; Krizman, D. B.
  3. Proteomics. 2001 1(10): 1271-1278.
  1. 18.   Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice
  2. Noonan, F. P.; Otsuka, T.; Bang, S.; Anver, M. R.; Merlino, G.
  3. Cancer Research. 2000 60(14): 3738-3743.
  1. 19.   High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
  2. Wistuba, II; Behrens, C.; Virmani, A. K.; Mele, G.; Milchgrub, S.; Girard, L.; Fondon, J. W.; Garner, H. R.; McKay, B.; Latif, F.; Lerman, M. I.; Lam, S.; Gazdar, A. F.; Minna, J. D.
  3. Cancer Research. 2000 60(7): 1949-1960.
  1. 20.   Role of the alternative INK4A proteins in human keratinocyte senescence: Evidence for the specific inactivation of p16(INK4A) upon immortalization
  2. Munro, J.; Stott, F. J.; Vousden, K. H.; Peters, G.; Parkinson, E. K.
  3. Cancer Research. 1999 59(11): 2516-2521.
  1. 21.   Chromosomal Changes Observed in Immortalized Human Keratinocytes Transformed By Ionizing Radiation
  2. Hukku, B.; Thraves, P.; Dritschilo, A.; Rhim, J. S.
  3. Cancer Genetics and Cytogenetics. 1997 93(2): 125-139.
  1. 22.   NO in Cancer-Carcinogenesis, Metastasis, and Therapy
  2. Somasundaram, Veena; Basudhar, Debashree; Greer, Madison; Cheng, Robert; Ridnour, Lisa; Wink, David
  3. 2017; 385-402.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel